Volume 12 Supplement 6
Publication of this supplement has not been supported by sponsorship. Information about the source of funding for publication charges can be found in the individual articles. The articles have undergone the journal's standard peer review process for supplements. The Supplement Editors declare that they have no competing interests.
Chicago, IL, USA08 July 2018
Edited by Emidio Capriotti, Yana Bromberg and Hannah Carter
Related articles have been published as a supplement to BMC Genomics and BMC Bioinformatics.
Not all the mutations are equally important for the development of metastasis. What about their order? The survival of cancer cells from the primary tumour site to the secondary seeding sites depends on the oc...
Genetic loss-of-function variants (LoFs) associated with disease traits are increasingly recognized as critical evidence for the selection of therapeutic targets. We integrated the analysis of genetic and clin...
The Correction to this article has been published in BMC Medical Genomics 2019 12:154
Perturbed posttranslational modification (PTM) landscapes commonly cause pathological phenotypes. The Cancer Genome Atlas (TCGA) project profiles thousands of tumors allowing the identification of spontaneous ...
The major histocompatibility complex class I (MHC-I) molecule is a protein complex that displays intracellular peptides to T cells, allowing the immune system to recognize and destroy infected or cancerous cel...
Citation Impact
3.622 - 2-year Impact Factor (2021)
3.554 - 5-year Impact Factor (2021)
0.879 - SNIP (Source Normalized Impact per Paper)
0.955 - SJR (SCImago Journal Rank)
Speed
32 days to first decision for all manuscripts (Median)
62 days to first decision for reviewed manuscripts only (Median)
Usage
983,595 Downloads (2021)
1,040 Altmetric mentions (2021)
The following summary describes the peer review process for this journal:
Identity transparency: Single anonymized
Reviewer interacts with: Editor
Review information published: Review reports. Reviewer Identities reviewer opt in. Author/reviewer communication